After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

Researchers reveal four distinct sequences of health conditions that commonly lead to Alzheimer’s, offering new hope for ...

Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...

Help Black families facing dementia. Join SHARE, a clinical trial for support, health, activities, resources, and education.

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...